Hanuveda

The Science of Ayurvedic Healing

Multiple Sclerosis Management in Ayurveda

 Critical Safety Notice

Do not stop your disease-modifying therapy (DMT).

Stopping certain MS medicines—particularly natalizumab and fingolimod—can trigger a rebound (including severe relapses and extensive new MRI lesions). Published studies have reported serious rebound after natalizumab withdrawal, and similar rebound is well documented after fingolimod cessation.

After stopping medicines, disease activity commonly returns within about three months, whether or not bridging treatment is used.

Your DMT remains an important foundation of MS care, while Ayurveda can play a complementary role in supporting the symptoms and overall wellbeing of people living with MS. 

Hanuveda’s Ayurvedic care focuses on the symptom burden of MS—including spasticity, pain, fatigue, bladder dysfunction—alongside your neurologist’s disease-modifying treatment.

What the Published Research Shows

The published Ayurvedic literature consists predominantly of individual case reports; rather that randomised controlled trials of Ayurvedic treatment for multiple sclerosis.

Management of Multiple Sclerosis Through Ayurveda: A Case Report- Journal of Ayurveda Case Reports. 2022;5(1). https://jaims.in/jaims/article/view/4

  • Outcomes of the research: A 28-year-old man with MS presented with balance difficulties, bilateral leg weakness and low back pain. The authors described an individualised, supportive Ayurvedic approach, interpreting his clinical presentation within the Ayurvedic framework of Vata Vyadhi.
  • At Hanuveda, we follow the same principle: Ayurvedic care for MS is personalised to the individual’s symptoms, functional needs and overall constitution, alongside ongoing neurological care.

Effect of Ayurvedic and Panchakarma Treatment in Asthi Majja Gata Vata (Primary Progressive Multiple Sclerosis): A Case Study https://jahm.co.in/index.php/jahm/article/view/370

  • Outcomes of the research: A 35-year-old woman with primary progressive MS presented with severe lower-limb weakness, sensory loss, and bowel and bladder dysfunction. The presentation was interpreted through the Ayurvedic framework of Asthi-Majja Gata Vata.
  • After 15 weeks of Ayurvedic care and physiotherapy, the report showed: Less pain and stiffness à Muscle power: Grade 0 to 3 à EDSS: 8.5 to 6.

Ayurvedic Management of Multiple Sclerosis: A Case Report https://jaims.in/jaims/article/view/4711

  • Outcomes of the research: A 68-year-old woman with a 29-year history of MS presented with walking difficulty, lower-limb weakness, bladder and bowel symptoms, and disturbed sleep. Her presentation was assessed as Pranavrita Vyana Vata with Majja Dhatu Kshaya and managed with an individualised Ayurvedic approach.
  • What These Reports Mean for MS Care
  • The published evidence is an encouraging observations around spasticity, pain, stiffness, mobility, sleep and other MS symptoms, while supporting an individualised approach to care.
  • At Hanuveda, Ayurveda complements disease-modifying treatment and neurological care, providing personalised symptom support without replacing established MS therapy.

How Ayurveda Understands Paralysis and Stroke?

In Ayurveda, MS is understood as an Anukta Vyādhi and interpreted mainly through the Vāta Vyādhi framework based on the individual’s symptoms and disease pattern.

Ayurvedic frameworks used in MS

  • Majja Gata/Asthi-Majja Gata Vāta: Vāta affecting marrow and nervous tissue, reflecting weakness, sensory loss and pain.
  • Majja Dhātu Kṣaya: Depletion of Majja Dhātu, reflecting progressive neurological decline.
  • Āvaraṇa: Vāta’s function is obstructed by another factor, conceptually resembling impaired nerve conduction; treatment focuses on Āvaraṇa-hara before general Vāta management.

The Ayurvedic Treatment Protocol for Multiple Sclerosis

MS needs a customized Ayurvedic plan. Standard Panchakarma may not suit every patient and can sometimes worsen symptoms, so therapies must be carefully adapted to the individual

Stage 0 — Assessment and neurological coordination

Before any therapy begins:

  • Confirm the MS type: Different types of MS behave differently and need different approaches.
  • Rule out similar conditions: Conditions such as NMOSD and MOGAD must be excluded by a neurologist.
  • Review current MS medication: Ayurvedic treatment is planned alongside—not against—your neurologist’s treatment. (Panchakarma is avoided during an acute relapse and the steroid-treatment period).
  • Assess overall strength (Bala): Treatment intensity is adjusted because many people with MS have limited energy and stamina. Mobility, balance, strength, hand function, fatigue, quality of life and bladder symptoms are documented to track progress.
  • Basic investigations: Liver and kidney function, vitamin D and urine testing are reviewed before treatment.

Three Key Changes in the MS Protocol

  • Heat is minimized MS makes you heat sensitive, which can temporarily worsen weakness, fatigue, vision or balance (Uhthoff’s phenomenon).
    We therefore avoid routine steam and excessive heat, using gentler or cooling therapies and monitoring temperature and symptoms throughout treatment.
  • Herbs are chosen cautiously
    As MS is an autoimmune condition, immune-stimulating herbs are not used routinely. Herbal choices are individualized, with preference for medicines aimed at supporting the nervous system. Any herb used is reviewed for safety, interactions and quality.
  • Fatigue sets the pace
    MS-related fatigue can be severe and treatment intensity is therefore adjusted to the patient’s energy and strength. Sessions are shorter, rest is built in, and with gentle therapies. Panchakarma is not forced when the patient cannot tolerate it; supportive (Shamana) treatment may be more appropriate.

Stage 1 — Deepana, Pachana and bowel and bladder management

Agni correction, plus targeted management of the two systems MS damages most predictably.

  •  Bowel: Constipation is common in MS. We address it with individualized Ayurvedic support, along with adequate fluids, fiber and a regular routine.
  • Bladder: Urgency, frequency and difficulty emptying are common. Incomplete emptying can increase UTI risk, and an infection can temporarily worsen MS symptoms (pseudo-relapse). We therefore screen appropriately and investigate new symptom worsening rather than assuming it is an MS relapse.

Stage 2 — Snehana (oleation)

  • External Abhyanga with medicated oil, at moderate rather than high temperature: Ksheerabala Taila, Dhanwantharam Taila, Mahanarayana Taila, Prasarini Taila, Nirgundi Taila for spasticity. Massage is among the better-tolerated therapies in MS and addresses spasticity, pain and sleep together.
  • Internal Snehana — graded medicated ghee (Ksheerabala 101, Brahmi Ghrita), dosed to digestive capacity, with liver function monitoring, particularly in patients on DMTs that carry hepatic monitoring requirements.

Stage 3 — Modified Swedana

As described above: dry bolus fomentation preferred, temperature and duration restricted, cooling protocols in place, heat-sensitive patients treated without sudation where necessary.

Stage 4 — Shodhana, When Appropriate

  • Shodhana is used selectively, not routinely. The intensity and type of therapy are matched to the patient’s strength, symptoms and tolerance.
  • Gentle Virechana: Mild, carefully dosed purgation with close attention to hydration and bowel/bladder function.
  • Basti: The main Shodhana therapy described in published MS case reports. Different forms—such as Mātrā, Anuvāsana, Nirūha and Kṣāra Basti—may be considered based on individual needs.
  • Duration is individualized: Kāla Basti or Yoga Basti schedules are modified according to tolerance.
  • Bladder safety: Extra caution is needed with incomplete bladder emptying or recurrent UTIs, with appropriate screening before Basti.

Stage 5 — Shiro-chikitsa

  • Takradhara — the cooling alternative to Shirodhara, and our default in heat-sensitive patients. For anxiety, insomnia and burning dysaesthesia.
  • Shirodhara — where heat sensitivity is minimal, using tepid rather than hot medium.
  • NasyaAnu Taila or Ksheerabala Taila; used with care where swallowing or gag reflex is affected
  • Shiro Pichu / Thalapothichil — gentle, cooling options

 Stage 6 — Shamana & Rasayana

The focus is symptom support, strength and overall wellbeing—not immune stimulation. Medicines are selected individually and coordinated with ongoing MS treatment.

  • Nervous system & cognition: Brahmi, Mandukaparni, Shankhpushpi, Jatamansi
  • Inflammation: Haridra, Shallaki, Nirgundi, Rasna
  • Spasticity & pain: Nirgundi, Rasnadi preparations, Maharasnadi Kwatha, Dashamoolarishta
  • Strength & recovery: Bala, Ksheerabala, Balarishta
  • Herbo-mineral medicines: Used sparingly, with quality testing and appropriate liver/kidney monitoring. Vitamin D Levels are checked and supplementation coordinated with the neurologist when needed.

All medicines are individualized and reviewed for safety alongside the patient’s MS medications.

Stage 7 — The integrative component

  • Physiotherapy — spasticity management, gait training, balance, and strength work adapted for fatigue. Exercise in MS is beneficial and safe when appropriately paced.
  • Occupational therapy — energy conservation strategies, home adaptation, upper limb function
  • Speech and swallow therapy where indicated
  • Yoga therapy — adapted, cooling-oriented practice; gentle Pranayama. Avoid hot-room practice entirely.
  • Cooling strategies — practical education on cooling vests, ambient temperature, timing of activity, avoiding hot baths. Simple and often overlooked.
  • Diet — anti-inflammatory pattern, adequate fibre and fluid for bowel and bladder function, vitamin D, weight management. Warm, easily digestible food per classical guidance, integrated with these.
  • Sleep and mood — depression is common in MS and undertreated, and it drives fatigue. We screen and refer.
  • Caregiver and family education — including how to recognise a possible relapse and when to contact the neurologist rather than us.
  • Safety — Our Commitment
  • Never stop or reduce MS medicines: Ayurvedic care is used alongside your neurologist’s treatment.
  • No treatment during an acute relapse: Relapses are managed by your neurologist first.
  • Investigate new symptoms: Heat, infection or fever can temporarily worsen symptoms (pseudo-relapse). New or worsening symptoms are assessed—not dismissed as “detox.”
  • No false cure claims: Natural recovery between relapses is not attributed to Ayurveda.
  • Verified medicines: Herbs are authenticated, quality-tested and sourced responsibly.
  • Regular monitoring: Liver and kidney function are monitored when appropriate.
    Open coordination: Your neurologist receives a clear record of the Ayurvedic medicines and therapies being used.

What Outcomes Can Be Expected ?

Ayurvedic treatment in MS is symptomatic and supportive. It is not disease-modifying. Those outcomes belong to disease-modifying therapies, which have been tested in large randomised trials. What we work on is the daily symptom burden — which is what most patients with MS actually experience as their illness.

Outcomes we consider reasonable to expect

  • Reduced spasticity and stiffness. The most consistent finding across the case literature and the most reliable response to oleation, bolus fomentation and Basti therapy. One case report documented Modified Ashworth Scale improvement from 4 to 2.
  • Pain relief. Both spasticity-related pain and neuropathic discomfort commonly respond.
  • Improved sleep. Takradhara, Shirodhara and Abhyanga are consistently useful here, and better sleep reduces fatigue.
  • Improved bowel function. Reliable and often substantial. Constipation is one of the most correctable MS symptoms.
  • Better bladder symptom management — through routine, pelvic floor work, fluid strategy and reduced constipation, which mechanically worsens bladder function.
  • Reduced fatigue. Frequently reported, though fatigue is subjective and fluctuates, so we measure it with the Modified Fatigue Impact Scale rather than relying on impression.
  • Improved mood and quality of life. Often the largest measurable change, and a legitimate one — MSQOL-54 and MSIS-29 scores commonly move more than physical scores do.
  • Improved balance and walking — modest, and dependent on baseline. Note that in one published case the Berg Balance change was two points, which is within measurement noise. We do not oversell this.


Outcomes we do not claim

  • Replacement of DMTs. Actively unsafe to attempt.
  • Remyelination or reversal of MS
  • Guaranteed or fixed-percentage recovery.

Realistic timeline

  • Weeks 1–2: Sleep, bowel function and pain typically shift first. Spasticity begins to soften with regular oleation. Fatigue may briefly worsen as the body adjusts to the treatment schedule.
  • Weeks 3–8:  Spasticity, bowel and bladder function, walking, transfers, hand function and fatigue are reassessed, looking for measurable functional improvement rather than relying on symptoms alone.
  • Weeks 8–12: Quality of life measures typically show the clearest change. Physical scores move more modestly.
  • Beyond 3 months: A maintenance phase of home Abhyanga, internal medication, paced exercise and cooling strategy, with review at three to six months. Because MS fluctuates, protocols are reassessed rather than repeated.

How we measure it

  • We measure your progress objectively at baseline, week 4 and week 12 using validated measures of walking, balance, strength, hand function, fatigue, quality of life and bladder symptoms.
    You receive the results, and so does your neurologist. If the numbers don’t improve, we inform and change the treatment plan.

FAQs

No. MS is a chronic autoimmune condition of the central nervous system and no system of medicine can currently cure it. Ayurvedic management here is supportive and symptomatic — spasticity, pain, fatigue, bladder and bowel function, sleep and mood. Anyone promising you a cure for MS is not being truthful with you.

? No, and please do not. Stopping natalizumab or fingolimod in particular can cause rebound disease activity — severe relapses with extensive new MRI lesions that can exceed your pre-treatment disease activity. DMTs are what reduce your relapse rate and protect against disability accumulation. Ayurvedic treatment here runs alongside them.

Because of heat sensitivity, known as Uhthoff's phenomenon. Raising core body temperature slows nerve conduction in demyelinated axons and causes temporary worsening of MS symptoms — blurred vision, weakness, worse fatigue, imbalance. It is reversible and does not cause new damage, but it is distressing and increases fall risk. We substitute dry bolus fomentation and cooling therapies such as Takradhara, and we keep treatment rooms cool.

We would not assume that. Worsening during MS treatment has several possible causes, and most of them are not the treatment: a urinary or other infection causing a pseudo-relapse, overheating, overexertion, or a genuine new relapse. We investigate rather than explain it away. Attributing new neurological symptoms in MS to "toxins being released" is how real relapses get missed.

Diet is one of the more useful things we work on. The goals are an anti-inflammatory eating pattern, adequate fibre and fluid for bowel and bladder function, adequate vitamin D, and weight management — integrated with classical guidance on warm, easily digestible food. We are careful not to over-promise here: no diet has been shown to modify MS disease course, but several dietary factors affect symptom burden and general health substantially.

No. Acute relapses are managed by your neurologist, usually with corticosteroids. We wait until the relapse has been treated and you have stabilised. Coming to us instead of your neurologist during a relapse delays treatment that is time-sensitive.

It depends on your strength, and we will tell you honestly if we think it is not appropriate. Panchakarma is physically demanding and purgation is depleting. For some patients the right answer is Shamana therapy — internal medication, diet, oil massage, home programme — with no Shodhana at all. We would rather deliver less and have you tolerate it than complete a protocol at your expense.

No — the opposite of what you want. MS involves an immune system attacking your own myelin. Herbs marketed as immune boosters, particularly Guduchi/Giloy, are best avoided. A published case series documented six patients developing autoimmune-like hepatitis after Tinospora consumption, which the authors connected to its immune-stimulant action. We use anti-inflammatory and nervine herbs instead, and we do not prescribe immune tonics in autoimmune disease.

Ayurveda Hospitals for Multiple Sclerosis Management

Phone
WhatsApp
WhatsApp
Phone